First Edition: July 7, 2023
Today's early morning highlights from the major news organizations.
Archives: Morning Breakouts
7,721-7,740 of 112,997 results
-
-
Research Roundup: Heart Disease; TB; Lyme Disease; Blood Cancer
Each week, KFF Health News compiles a selection of health policy studies and briefs.
By khnelysiag -
Viewpoints: Vaccine Distrust Is Waning; What Role Do Doctors Want AI To Take In Their Practices?
Editorial writers discuss vaccine skeptics, A.I. in medicine, overturning Roe and other public health issues.
By khnelysiag -
North Carolina’s Governor Vetoes Bills Aimed At Limiting LGBTQ+ Rights
The AP notes that there is a Republican supermajority in North Carolina, but nevertheless its Democratic governor has blocked bills limiting gender care for minors, restricting trans participation in school sports, and limiting what educators can say about gender and sexuality.
By khnlaureno -
That Worryingly High BMI Figure? It’s Not Linked To Higher Death Risk
NBC News reports on a new study that says BMI figures considered in the range of overweight or even obese are not necessarily linked with a higher risk of death. Separately, researchers have found that depression after a traumatic brain injury is its own condition, distinct from others.
By khnlaureno -
Delaware To Pilot First-Of-Its-Kind Test For Finding Tranq In Illegal Fentanyl
The Philadelphia Inquirer says tranq, a name for the animal tranquilizer xylazine, has contaminated the region's illegal drug supply, so the new test may help protect people from its dangers. Meanwhile, California's governor, also concerned over tranq, is updating the state's opioid plan to tackle it.
By khnlaureno -
Your Tap Water May Be Contaminated With Forever Chemicals, Says USGS
CNN reports that "almost half" of tap water in the U.S. is contaminated with pollutant PFAS chemicals considered dangerous to human health. And the U.S. Geological Survey couldn't even test for all PFAS variants. Skin cancer, environmental racism, and more are also in the news.
By khnlaureno -
FDA Expected To Fully Approve Alzheimer’s Drug Leqembi
The drug, from Eisai and Biogen, could trigger a "new era in treatment," according to Roll Call, and is expected to cost around $26,500 a year. However, critics say it's actually based on a flawed theory about the disease, while some predict that the drug could highlight racial disparities in elder care.
By khnlaureno -
Having Private Medicare Doesn’t Mean It’s Easy To Find A Psychiatrist: Study
More than half of the counties in a new study lacked even a single psychiatrist participating in a Medicare Advantage plan, The New York Times reports. Meanwhile, Eli Lilly is now the world's biggest health care company by market value, beating UnitedHealth.
By khnlaureno -
HIV Study: Antibody Drugs Can Be Used As Alternative Treatment In Children
It was the first time that broadly neutralizing antibodies were tested in combination with antiretroviral drugs against HIV in a pediatric population, Stat reported. Other news is on Humira, Wegovy, and more.
By khnlaureno -
Get Ready To Pull Up Your Sleeves For A Triple-Whammy Of Shots This Fall
Federal health officials are hatching plans to roll out new covid, RSV, and flu shots. Everyone should at least get flu and covid jabs, experts say.
By khnlaureno -
Study: People With Cannabis Disorder More Likely To Have Surgical Trouble
The most significant complications, the study found, were for blockages of coronary arteries, stroke, injury to the kidneys, blood clots, breathing trouble, infection, and in-hospital death, CNN reported.
By khnlaureno -
Determined To Outlaw Abortion, Iowa’s GOP Governor Calls Special Session
The special session is scheduled to begin less than a month after the Iowa Supreme Court deadlocked on Gov. Kim Reynolds’ request to reinstate the “fetal heartbeat” law she signed in 2018, Iowa Public Radio reported. And in Ohio, a rape case that made national headlines comes to an end.
By khnlaureno -
First Edition: July 6, 2023
Today's early morning highlights from the major news organizations.
By khnlaureno -
Plan To Tackle Generic-Drug Shortages; Potential Lyme Disease Vaccine Shows Promise
Read recent pharmaceutical developments in KFF Health News' Prescription Drug Watch roundup.
By khnelysiag -
Perspectives: Ideas to Make Scripts More Affordable; Stricter Regulation Needed In Generic Drug Market
Read recent commentaries about drug-cost issues.
By khnelysiag -
Viewpoints: Wildfire Smoke Especially Harmful To Children; Here’s How To Tackle Youth Mental Health
Editorial writers weigh in on these public health topics.
By khnelysiag -
A Focus On The Education Of Future Medical Staff As Affirmative Action Ends
News outlets report on the repercussions for the medical education industry of the Supreme Court's ruling that overturns affirmative action. The New York Times reports on how the socioeconomic disadvantage scale may be used as a tool to filter med school applicants.
By khnkit -
It’s Getting So Hot In Texas, Even The Mosquitos Can’t Cope
The Houston Chronicle, reporting on new data that show that "mosquito days" in Houston fell between 1979 and 2022, reminds us that mosquito bites can be both annoying and dangerous. Among other news: the Ohio toxic train derailment, and a dispute over human remains disposal in North Dakota.
By khnkit -
Data Dispute Threatened Disruption To The Organ Transplant System
The Washington Post reported that 63 U.S. transplant centers were at risk of having supply chains for human organs disrupted by a dispute over health data on transplanted organs with an organ screening company. Also in the news: a Parkinson's drug, a lawsuit over HIV medication, and more.
By khnkit